Health Minister, Joe Phaahla, made the announcement during a media briefing following a meeting with Health MECs held in Centurion on Thursday, 12 October.
Phaahla noted that South Africa continues to experience outbreaks of vaccine-preventable diseases, despite a strong childhood vaccination programme.
He said there is an ongoing need to improve coverage of existing vaccines and add new vaccines to the expanded programme on the immunisation schedule.
The minister said the department is introducing a better packaged/derived vaccine that will prevent whooping cough, tetanus and diphtheria and reduce the chances of these conditions resurfacing within the communities.
“We are also introducing a combination vaccine of measles and rubella that will protect young girls, particularly during pregnancy which may lead to birth defects,” Phaahla said.
He said all these changes, recommended by the ministerial-appointed National Advisory Group on Immunisation (Nagi), will be implemented with effect from January 2024.
The minister also announced that the Department of Home Affairs has made budget provision for the set-up and operational costs for the expansion of the Online Registration System by an additional 91 health facilities during the 2023/24 financial year.
This forms part of collaborative efforts between the departments of health and Home Affairs to ensure that all births are registered on time, through the Online Birth Registration system, which has been rolled out in 161 health facilities with the ability to issue birth certificates on the spot.
“These facilities will be allocated to full-time Home Affairs officials to provide birth registration service during office hours. The establishment of the system in these new facilities will commence by the end of October 2023. This initiative will go a long way in providing early birth registration,” Phaahla said.
Meanwhile, the minister announced that the department has decided to make a number of changes related to Covid-19 vaccinations, which include transitioning from a mass vaccination campaign to integrate vaccination into routine primary healthcare services.
This is in line with World Health Organisation (WHO) recommendations.
Phaahla said the current available Pfizer vaccine stock purchased as part of the Covid-19 national vaccination rollout will expire at the end of October 2023, while the J&J vaccine doses will expire at the end of February 2024.
The Electronic Vaccination Data System (EVDS) will continue to record all Covid-19 vaccinations until 29 February 2024, thereafter those vaccinated will receive a paper-record of vaccination, but they will still be able to download vaccination certificates as long as they have at least one vaccination code.
“The department plans to procure vaccines for administration in the public sector and will continue to work with the private sector to facilitate availability of vaccines. All restrictions limiting procurement of vaccines by private-sector providers will be lifted,” Phaahla explained.
He added that the investigation and causality assessment of Covid-19 vaccination-related Adverse Events Following Immunisation (AEFIs) will continue and mechanisms for processing No Fault Compensation Scheme claims will be retained.
Phaahla also gave an update on various issues affecting the public health system, including cost-containment measures; audit outcomes and performance against targets; and medico-legal claims, among others.
